Bill Ericson has been working with startups his entire career as a founder, key advisor, counselor and investor. He believes that entrepreneurship drives the American economy, and that the best venture capitalists see their role as supporting and challenging entrepreneurs to their best performance.
Mohr Davidow requires its partners to define an investment strategy, driven by equal doses of passion and analysis. “It’s important to have a clear view of the largest unsolved problems and very deep domain expertise to be able to help great entrepreneurs tackle those problems,” Bill says. “Just as important is the willingness to push beyond safe boundaries.”
Bill’s current areas of investment focus are the Digitization of Health Care, Cloud Enterprise and Infrastructure and Quantitative Marketing and Advertising.
Bill believes that we are in a transitional phase to the “mass personalization of everything,” which creates large opportunities for innovative computer science to enable a more actionable and data driven enterprise and consumer experience.
“Our mission is to partner with entrepreneurs at the very earliest stage of development,” he says. “That requires patience and stamina from both the investor and entrepreneur. Some of the best companies we’ve funded are those who managed their way through difficulty.”
Over the past decade, Bill has led investments in transformative technology companies including now public Rocket Fuel (NASDAQ: FUEL), Pacific Biosciences (NYSE: PACB), and Adamas Pharmaceuticals (NASDAQ: ADMS), and successfully acquired companies Ticketfly (acquired by NASDAQ:P), Verinata (acquired by NASDAQ:ILMN), OpenDNS (acquired by NASDAQ:CSCO), Sabrix (acquired by NYSE:TRI), Rosetta Inpharmatics (NASDAQ: RSTA, acquired by NYSE:MRK), Sequenta (acquired by Adaptive Biotechnologies) and Parallele (acquired by NASDAQ:AFFX). Bill’s current private companies include Healthtap, Splice Machine, Navera, Neon Labs, Visible Measures, Audience Science, nLight Photonics and RainDance Technologies.